Herpes simplex virus type 1 variants arising after selection with an antiviral carrageenan: Lack of correlation between drug susceptibility and syn phenotype
- 24 July 2002
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 68 (1) , 92-98
- https://doi.org/10.1002/jmv.10174
Abstract
Natural carrageenans of diverse structural types isolated from the red seaweed Gigartina skottsbergii were recently identified as potent and selective inhibitors of herpes simplex virus types 1 and 2 (HSV-1 and -2). The μ/ν-carrageenan 1C3 was tested in vitro for its ability to select resistant variants. After serial passages of HSV-1 strain F in Vero cells in the presence of increasing concentrations of 1C3, viruses emerged that were approximately 2- to 10-fold more resistant to 1C3 inhibition than parental virus; these viruses formed large plaques with an altered syncytial phenotype (1C3-syn). Plaque-purified syncytial variants isolated from passages 13 and 14 have shown variable levels of resistance to 1C3, as well as to the other antiviral carrageenans isolated from G. skottsbergii and to other sulfated polysaccharides with known antiviral activity, such as heparin and dextran sulfate 8000, but all the clones were susceptible to acyclovir. The syn phenotype was not related to polysaccharide resistance. All the 1C3-syn variants formed large syncytia in Vero and CV-1 cells but did not induce fusion in other cell types. The growth efficiency in Vero cells, as well as the virulence for mice by intracerebral or intraperitoneal inoculation of 1C3-syn variants, showed no significant alterations in comparison with the parental virus. The syncytial properties were not affected by cyclosporine or melittin, suggesting that an alteration on glycoprotein gB could be responsible for the syn phenotype induced by 1C3. J. Med. Virol. 68:92–98, 2002.Keywords
This publication has 33 references indexed in Scilit:
- Antiviral resistance: mechanisms, clinical significance, and future implicationsJournal of Antimicrobial Chemotherapy, 1996
- Single amino acid substitutions in the glycoprotein B carboxy terminus influence the fusion from without property of herpes simplex virus type 1Journal of General Virology, 1995
- Acyclovir-resistant, pathogenic herpesvirusesTrends in Microbiology, 1994
- Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein BJournal of General Virology, 1994
- Cyclosporin a resistance of Herpes simplex virus-induced “fusion from within” as a phenotypical marker of mutations in the syn 3 locus of the glycoprotein B geneVirus Genes, 1994
- A Controlled Trial Comparing Foscarnet with Vidarabine for Acyclovir-Resistant Mucocutaneous Herpes Simplex in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1991
- Phenotypic and genotypic characterization of locus Syn 5 in herpes simplex virus 1Virus Research, 1991
- Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virusAntimicrobial Agents and Chemotherapy, 1988
- Thymidine Kinase Deletion Mutants of Herpes Simplex Virus Type 1Journal of General Virology, 1982
- Resistance to Antiviral Drugs of Herpes Simplex Virus Isolated from a Patient Treated with AcyclovirNew England Journal of Medicine, 1982